EP Patent

EP1603858A2 — Kcnq channel modulating compounds and their pharmaceutical use

Assigned to NTG Nordic Transport Group AS · Expires 2005-12-14 · 20y expired

What this patent protects

This invention relates to compounds of the general formula (I) useful as modulators of the KCNQ channel, to pharmaceutical compositions comprising these compounds, and to methods of treatment herewith.

USPTO Abstract

This invention relates to compounds of the general formula (I) useful as modulators of the KCNQ channel, to pharmaceutical compositions comprising these compounds, and to methods of treatment herewith.

Drugs covered by this patent

Patent Metadata

Patent number
EP1603858A2
Jurisdiction
EP
Classification
—
Expires
2005-12-14
Drug substance claim
No
Drug product claim
No
Assignee
NTG Nordic Transport Group AS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.